Radcliffe Capital Management’s Healthcare AI Acquisition Corp. Class A Ordinary Shares HAIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,460
Closed -$154K 498
2023
Q2
$154K Sell
14,460
-520,393
-97% -$5.48M 0.01% 235
2023
Q1
$5.58M Buy
534,853
+28,834
+6% +$299K 0.35% 87
2022
Q4
$5.2M Buy
506,019
+1,817
+0.4% +$18.4K 0.16% 192
2022
Q3
$5.08M Buy
504,202
+200
+0% +$2K 0.12% 266
2022
Q2
$5M Buy
504,002
+3,011
+0.6% +$30K 0.11% 270
2022
Q1
$4.96M Buy
+500,991
New +$4.94M 0.11% 236

Other funds holding HAIA

Radcliffe Capital Management's HAIA Position: Q3 2023 in Review

Radcliffe Capital Management sold out of Healthcare AI Acquisition Corp. Class A Ordinary Shares (HAIA) in Q3 2023, closing a stake of 14,460 shares — an estimated $154K sold.

Radcliffe Capital Management first reported a position in HAIA in Q1 2022 and held it in 6 quarters. The position peaked at $5.58M in Q1 2023. 7 funds tracked by Wall St. Rank hold HAIA as of Q3 2023.

  • Radcliffe Capital Management reported no remaining Healthcare AI Acquisition Corp. Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 14,460 Healthcare AI Acquisition Corp. Class A Ordinary Shares shares in Q3 2023, an estimated $154K.
  • Radcliffe Capital Management first reported a position in Healthcare AI Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 6 quarters.
  • Radcliffe Capital Management's Healthcare AI Acquisition Corp. Class A Ordinary Shares position peaked at $5.58M in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Class A Ordinary Shares as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.